Background and Design:
Seventeen patients with subacute cutaneous lupus erythematosus (SCLE) were compared with 15 patients with discoid lupus erythematosus (DLE) to evaluate the relationship of 60- and 52-kd Ro/SSA autoantibodies to the clinical diagnosis and to evaluate assays for anti-Ro/SSA.
All serum samples from patients with SCLE had precipitating anti-Ro/SSA antibodies in immunodiffusion, and all had high titer anti—60-kd Ro/SSA in enzyme-linked immunosorbent assay. Immunoblotting was inadequately sensitive for detecting anti—60-kd Ro/SSA. Fifteen patients with SCLE had anti—52-kd Ro/SSA (11 high titer, four low titer). Only one of the 15 patients with DLE had precipitating, high-titer anti-Ro/SSA. Nine other patients with DLE had low-titer anti—60-kd Ro/SSA, and four had low-titer anti— 52-kd Ro/SSA. Low-titer anti-Ro/SSA did not confer an increased risk for photosensitivity in the DLE group.
High-titer, precipitating antibodies to Ro/SSA are typical of SCLE and unusual in DLE. Lowtiter, nonprecipitating antibodies to Ro/SSA are common in DLE and could be an indication of pathogenic factors shared with SCLE. However, low titers of antiRo/SSA do not confer a significant risk for SCLE skin lesions. For the purpose of clinical evaluation of skin disease, immunodiffusion assays for anti-Ro/SSA are cost-effective and informative.(Arch Dermatol. 1994;130:1262-1268)
Lee LA, Roberts CM, Frank MB, McCubbin VR, Reichlin M. The Autoantibody Response to Ro/SSA in Cutaneous Lupus Erythematosus. Arch Dermatol. 1994;130(10):1262-1268. doi:10.1001/archderm.1994.01690100046006